Why Brown & Brown Stock Slumped by 5% Today

Brown & Brown (BRO) stock fell 5% after Q3 earnings missed estimates. Revenue rose 7% YoY to $1.73B, below the $1.76B consensus. GAAP net income increased 6% to $240M, while adjusted EPS grew 2% to $1.07, missing the $1.09 estimate. The company cited a challenging rate environment and attributed some growth to its Accession acquisition, but organic revenue grew only 1% YoY to $1.46B.

Original reporting
Published Oct 27, 2026, 10:25 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 10:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Why Brown & Brown Stock Slumped by 5% Today — source image
Decision brief

The 30-second read

$BROBearishHigh
01

Why it matters

The earnings miss is the primary catalyst for the stock move, suggesting short‑term downside risk.

02

Market read

First‑report earnings miss for a mid‑cap insurer, immediate price impact, sector‑wide relevance.

03

What to watch

Organic revenue growth is only ~1% YoY, indicating deeper structural challenges beyond the earnings miss.

Relevance 8/10Novelty 9/10Timing: today

Background

Brown & Brown reported Q3 results after market close, missing consensus estimates and prompting a 5% slide.

Company-level read

Ticker impact

$BROBearishHigh confidence
Context

Q3 earnings missed revenue ($1.73B vs $1.76B estimate) and EPS ($1.07 vs $1.09 estimate), triggering a ~5% stock decline.

Expected impact

likely further downside as investors price in weaker top‑line and earnings.

Evidence & confidence

The miss was disclosed for the first time and already moved the stock 5% lower; market reaction is immediate.

Market effects

Insurance sector may face broader scrutiny as earnings miss highlights rate‑environment pressure.

U.S. equity markets could see modest pullback in insurance‑related stocks.

Limited to U.S. insurers; no immediate global ripple.

Counterpoint

The miss may be temporary; underlying acquisition synergies could support a rebound.

Key entities

  • Brown & Brown

    U.S. diversified insurance agency (ticker BRO).

Related articles

$BROMed

Brown & Brown Inc (BRO) (Q3 2026) Earnings Call Highlights: Revenue Up 7.4%

Brown & Brown Inc (BRO) reported Q3 2026 revenue up 7.4% to $1.07B, but adjusted EBITDAC margin fell 200 bps to 34.6%. Specialty Distribution organic revenue declined 0.8%, missing expectations due to competition and pricing pressures. The company anticipates further declines in Q4 and faces ongoing litigation impacts. Integration costs for Accession have increased to $250-300M.

$BROMed

What Brown & Brown (BRO) Said on Its Q3 Earnings Call

Brown & Brown (BRO) reported Q3 earnings, noting market shifts in California and Texas, and pricing pressures in commercial earthquake business. The company expects 2027 growth of 2%-4% for retail and 1%-3% for specialty distribution. Accession acquisition raised synergy targets to $50M for 2026 and $175M by 2028. AI initiatives are expanding across the company, with tools like Claude and COMPASS being deployed. The board increased the dividend by 9%.

$BROHighAI 8/10

Brown & Brown (BRO) Q3 2026 Earnings Call Transcript

Brown & Brown (BRO) reported Q3 2026 revenues of $1.7B, up 7.4% YoY. Organic revenue grew 1.2%, while adjusted EBITDAC margin fell 200 bps to 34.6%. Adjusted EPS rose 2% to $1.07. The company raised its dividend by 9%, marking 33 consecutive years of increases. Retail segment outperformed expectations, while specialty distribution faced headwinds. The company repurchased $750M in shares YTD, including $250M in Q3.